Position in ATRA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,113
+$1,109 QoQ
Shares Held
97
+9600.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 36 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. ATRA ranks #346 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in ATRA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,113 | 97 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $4 | 1 | Shares | Defined | 2026-05-11 | |
| 2024-12-31 | $26 | 2 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $65 | 8 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $26,962 | 3,172 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $12,967 | 18,686 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $7,186 | 14,010 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $670,590 | 453,102 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $775,609 | 481,745 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $2,642,534 | 911,219 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,363,370 | 1,025,418 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $4,874,804 | 1,289,631 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $8,051,307 | 1,033,544 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $8,037,187 | 865,144 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $15,969,277 | 1,013,279 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $4,848,197 | 270,849 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $6,676,299 | 429,344 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $6,149,181 | 428,216 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $24,808,099 | 1,263,785 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,272,808 | 175,371 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,277,725 | 224,964 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,830,824 | 215,138 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||